These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6305545)
21. Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Lindgren JE; Ohlsson A; Agurell S; Hollister L; Gillespie H Psychopharmacology (Berl); 1981; 74(3):208-12. PubMed ID: 6267648 [TBL] [Abstract][Full Text] [Related]
22. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. Smith-Kielland A; Skuterud B; Mørland J J Anal Toxicol; 1999 Sep; 23(5):323-32. PubMed ID: 10488918 [TBL] [Abstract][Full Text] [Related]
23. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin. Law B; Mason PA; Moffat AC; Gleadle RI; King LJ J Pharm Pharmacol; 1984 May; 36(5):289-94. PubMed ID: 6145762 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats. Ravula A; Chandasana H; Jagnarine D; Wall SC; Setlow B; Febo M; Bruijnzeel AW; Derendorf H Cannabis Cannabinoid Res; 2019; 4(4):240-254. PubMed ID: 32042924 [No Abstract] [Full Text] [Related]
26. Acute effects of natural and synthetic cannabis compounds on prolactin levels in human males. Mendelson JH; Ellingboe J; Mello NK Pharmacol Biochem Behav; 1984 Jan; 20(1):103-6. PubMed ID: 6320226 [TBL] [Abstract][Full Text] [Related]
27. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay. ElSohly MA; Jones AB; ElSohly HN J Anal Toxicol; 1990; 14(5):277-9. PubMed ID: 2175818 [TBL] [Abstract][Full Text] [Related]
28. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH). Huestis MA; Henningfield JE; Cone EJ J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216 [TBL] [Abstract][Full Text] [Related]
29. Comparison of 3H- and 125I-radioimmunoassay and gas chromatography/mass spectrometry for the determination of delta 9-tetrahydrocannabinol and cannabinoids in blood and serum. Hanson VW; Buonarati MH; Baselt RC; Wade NA; Yep C; Biasotti AA; Reeve VC; Wong AS; Orbanowsky MW J Anal Toxicol; 1983; 7(2):96-102. PubMed ID: 6304423 [TBL] [Abstract][Full Text] [Related]
30. Monitoring urine for inhaled cannabinoids. Moffat AC Arch Toxicol Suppl; 1986; 9():103-10. PubMed ID: 3028322 [TBL] [Abstract][Full Text] [Related]
31. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis. Aizpurua-Olaizola O; Zarandona I; Ortiz L; Navarro P; Etxebarria N; Usobiaga A Drug Test Anal; 2017 Apr; 9(4):626-633. PubMed ID: 27341312 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of delta-9-tetrahydrocannabinol following acute cannabis smoke exposure in mice; effects of sex, age, and strain. Gazarov EA; Zequeira S; Senetra AS; Howard J; Sharma A; McCurdy CR; Lewis J; Bizon JL; Setlow B Front Pharmacol; 2023; 14():1227220. PubMed ID: 37701025 [TBL] [Abstract][Full Text] [Related]
33. Homogeneous enzyme immunoassay for cannabinoids in urine. Rodgers R; Crowl CP; Eimstad WM; Hu MW; Kam JK; Ronald RC; Rowley GL; Ullman EF Clin Chem; 1978 Jan; 24(1):95-100. PubMed ID: 338202 [TBL] [Abstract][Full Text] [Related]
34. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood. Moody DE; Rittenhouse LF; Monti KM J Anal Toxicol; 1992; 16(5):297-301. PubMed ID: 1338217 [TBL] [Abstract][Full Text] [Related]
35. The therapeutic use of cannabinoids: Forensic aspects. Indorato F; Liberto A; Ledda C; Romano G; Barbera N Forensic Sci Int; 2016 Aug; 265():200-3. PubMed ID: 27038587 [TBL] [Abstract][Full Text] [Related]
36. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry. Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938 [TBL] [Abstract][Full Text] [Related]
37. Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana. Johansson E; Halldin MM; Agurell S; Hollister LE; Gillespie HK Eur J Clin Pharmacol; 1989; 37(3):273-7. PubMed ID: 2558889 [TBL] [Abstract][Full Text] [Related]
38. Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users. Ohlsson A; Lindgren JE; Wahlén A; Agurell S; Hollister LE; Gillespie HK Biomed Mass Spectrom; 1982 Jan; 9(1):6-10. PubMed ID: 6277407 [TBL] [Abstract][Full Text] [Related]
39. Disposition of smoked cannabis with high Δ(9)-tetrahydrocannabinol content: a kinetic model. Hunault CC; van Eijkeren JC; Mensinga TT; de Vries I; Leenders ME; Meulenbelt J Toxicol Appl Pharmacol; 2010 Aug; 246(3):148-53. PubMed ID: 20450927 [TBL] [Abstract][Full Text] [Related]
40. Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette. Marsot A; Audebert C; Attolini L; Lacarelle B; Micallef J; Blin O J Pharm Pharm Sci; 2016; 19(3):411-422. PubMed ID: 27806250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]